Literature DB >> 6112093

Clinical processes and central dopaminergic activity in psychotic disorders.

M B Bowers, G R Heninger, D Sternberg, H Y Meltzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6112093

Source DB:  PubMed          Journal:  Commun Psychopharmacol        ISSN： 0145-5699


× No keyword cloud information.
  4 in total

1.  Greater vulnerability to the amnestic effects of ketamine in males.

Authors:  Celia J A Morgan; Edward B Perry; Hyung-Sang Cho; John H Krystal; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-08-01       Impact factor: 4.530

2.  Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine.

Authors:  Hyun-Sang Cho; Deepak C D'Souza; Ralitza Gueorguieva; Edward B Perry; Steven Madonick; Laurence P Karper; Anissa Abi-Dargham; Aysenil Belger; Walid Abi-Saab; Deborah Lipschitz; Alexandre Bennet; John P Seibyl; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

3.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  Time of Day-Dependent Alterations in Hippocampal Kynurenic Acid, Glutamate, and GABA in Adult Rats Exposed to Elevated Kynurenic Acid During Neurodevelopment.

Authors:  Courtney J Wright; Katherine M Rentschler; Nathan T J Wagner; Ashley M Lewis; Sarah Beggiato; Ana Pocivavsek
Journal:  Front Psychiatry       Date:  2021-09-17       Impact factor: 4.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.